mTORC1 is the most famous molecular switch in aging research, yet how it gets turned on at the Golgi has stayed murky. A 2026 study shows the Golgi protein YIF1A recruits RNF126 to degrade G3BP1/2, releasing the brake on mTORC1; cells with YIF1A knocked down resist induced senescence, and worm experiments reveal the pathway tunes lifespan in both directions.
LoRA and QLoRA let you fine-tune a large language model with just a few dozen examples on your own computer, no cloud GPU rental, no uploading sensitive data. A real biotech lab case shows why this technique changes how local AI feels to use.
Google agents-cli uses a three-tier SkillToolset progressive disclosure architecture that cuts baseline context token consumption by about 90% in static scenarios, though real-world workloads may narrow that to 37%. This piece dissects the token-efficiency claim, the vendor lock-in risk, and the fragility of description-based routing, extracting lessons useful for any independent agent system.
Four 2026 studies converge on one conclusion: brain aging is not the brain's problem alone. Peripheral CD8⁺ EMRA T-cell immunosenescence, plasma glucose with Mendelian Randomization causal evidence, and arterial wall cellular heterogeneity collapse are converging on the aging brain — while intracranial microglia and oligodendrocytes inflammage in near-perfect synchrony (Pearson r≈0.98). Understanding this multi-source siege reframes what prevention might realistically look like.
113 studies. Clear biological activity, inconclusive clinical benefit. A close read of the 2026 PRISMA review: what NR/NMN actually do, what they don't, and what often gets left out of the conversation.
I benchmarked five 4-bit local models on a single M4 Pro (48GB) with oMLX across eight benchmarks, mapped the speed/quality sweet spot, and calibrated which cloud generation they match. Plus a field report on three speculative-decoding traps (MTP / dflash / specprefill) and the cache trade-off that decides them.